G20
Conditions
Interventions
Group 1: a) Treadmill training with rhythmic auditive stimulation (4/4 beat, songs), with changing speed, a rope to hold on or a rehabilitation belt for warm-up, 10-15 min
b) Task- oriented training o
Sponsors
Freiraum Physiotherapie
Eligibility
Sex/Gender
All
Age
18 Years to 999 Years
Inclusion criteria
Inclusion criteria: Males and females with idiopathic Parkinson’s Disease based on the UK Brain Bank criteria (Hughes et al., 1992), Stage 2.5-4.0 on the Hoehn & Yahr scale, ON Medication (Hoehn and Yahr, 1967), age 18-999 years, any ethnicity, Mini-Mental-Status-Examination (MMSE) =24/30 (Tombaugh and McIntyre, 1992) stable dosage of dopaminergic replacement therapy min. 3 weeks before the start of the study or without dopaminergic treatment for the duration of the study intervention, fluent in spoken and written German language.
Exclusion criteria
Exclusion criteria: Concomitant disease(s) (such as malignant diseases, other neurological, orthopaedic, cardiac or psychiatric diseases, major depression, dementia), non-Parkinson’s walking impairment (e.g., due to musculoskeletal symptoms), recent surgical intervention, untreated pain, uncorrected visual or auditory impairment, which would affect training or testing, pregnancy, recent deep brain stimulation (DBS) or change in DBS parameters within the last year, severe motor fluctuations, initiation of a new dopaminergic medication or adaptation thereof within the study period is not foreseen; in the sense of a real-life setting, this decision is the responsibility of the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postural control as measured by the Mini - Balance Evaluation Systems Test (BESTest), which also includes the Timed Up & Go with Dual Task | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Fall-related self-efficacy measured by Falls Efficacy Scale (FES-I) 2. Fall rate, based on the number of falls within 12 weeks before study inclusion, within the active phase (intervention) of the study and in the 12-week follow-up period 3. Walking speed, measured by the 10-Meter Walk Test (10MWT) 4. Walking distance, measured by the 6-Minute Walk Test (6MWT 5. Mobility as measured by the Timed Up and Go (TUG) test 6. Dynamic balance, measured using the Functional Reach Test (FRT) 7. Health-related quality of life, measured using the Parkinson’s Disease Questionnaire-39 (PDQ-39) 8. Feasibility of a larger randomised parallel study based on recruitment rate, retention rate, adherence rate and high safety due to absence of or low/mild adverse events/side effects | — |
Countries
Austria
Contacts
Public ContactBelinda Böhm
Freiraum Physiotherapie
Outcome results
None listed